BSE filing, NSE: AFFLE. Summary written from the filing by ALFA Finder's alert engine.
Affle 3I Ltd: key numbers
- Share price
- ₹1,608.20
- Market cap
- ₹23,141 Cr
- Revenue (annual)
- ₹2,709 Cr
- Net profit (annual)
- ₹454.9 Cr
- P/E (TTM)
- 46.6×Sector 23.7×
- Promoter holding
- 55.82%+0.91% QoQ
- FII holding
- 14.23%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Affle 3I Ltd
All →Affle 3I Employee Stock Options
Affle 3i Ltd disclosed an ESOP-related sale of 687 shares by the Affle (India) Employees Welfare Trust to an employee exercising options. Holding fell from 222,427 to 221,740 shares, roughly 0.10% unchanged.
- Value
- ₹0.11 Cr
Affle 3I Employee Stock Options
Affle 3i disclosed PIT trades on 2-4 November 2026 covering ESOP-related transfers and designated-person purchases. Rows total about Rs.0.42 Crore in value.
Affle 3I Acquisition Worth ₹3,990 Cr
Affle 3i's step-down subsidiary will acquire Perion Network in an all-cash deal valued at about ₹3,990 Crore. Closing is expected in early 2027.
- Value
- ₹3,990 Cr
- Execution
- Expected to close in early 2027
Affle 3I Results Update
Affle 3i reports Q2 FY2027 revenue of Rs 783.6 crore, up 21.2% y-o-y, with EBITDA up 24.2%. PAT rose 17.4% to Rs 129.8 crore.
Affle 3I Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 7,836 mn (+21.2% YoY), EBITDA INR 1,814 mn (23.2% margin), PAT INR 1,298 mn (+17.4%). H1 revenue +20.8%, PAT +19.5%. CPCU conversions +18.2% YoY.
Affle 3I Q2 FY27 Results: Net Profit ₹129.8 Cr, Up 17.5% YoY
Affle 3I Ltd reported revenue from operations of ₹783.6 Cr (+21.2% YoY) and net profit of ₹129.8 Cr (+17.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹129.8 Cr · +17.5% YoY
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr